Introduction - Uppsala Monitoring Centre

Kereković M and Curković M. Olfactoxicity of streptomycin. Int Rhinol (Leiden) 1971; 9: 97–8.
Kerr CE, Milne I and Kaptchuk TJ. William Cullen and a missing mind-body link in the early history of placebos. J R Soc Med
2008; 101: 89–92.
Ketham J. de. The Fasciculus Medicinae of Johannes de Ketham, Alemanus : facsimile of the first (Venetian) edition of 1491.
With English translation by Luke Demaitre; commentary by Karl Sudhoff; trans. and adapted by Charles Singer. (Birmingham,
Ala.): The Classics of Medicine Library, 1988.
Key George. A dissertation on the effects of mercury on human bodies, in the cure of the venereal disease, London, 1747.
Kingcade GF, Saxton GD, Morse Pwand and Mathisen AK. Streptomycin in the treatment of tuberculosis. Can Med Assoc J
1948; 59: 105–112.
King S. A Fylde Country Practice. Medicine and Society in Lancashire, circa 1760–1840. Centre for North-West Regional Studies
at the University of Lancashire. 2001. p45.
King’s American Dispensatory 1898 www.henriettesherbal.com.
King, Vierteljahrschr Dermatologie und Syphilis, 1879; p370.
Kitchener S, Malekottodjary N and McClelland GR. Adverse effects from placebo-treated healthy volunteers. Br J Clin
Pharm 1996; 41: 473P.
Kono R. Subacute myelo-optic-neuropathy, A new neurological disease prevailing in Japan. Jpn J Med Sci Biol 1971; 24: 195-
216.
Kotslas BA. Scopolamine and the murder of King Hamlet. Arch Otolaryngol Head Neck Surg. 2002; 128: 847–849.
Koutsaimanis DG and Wardener HE de. Phenacetin nephropathy, with particular reference to the effect of surgery. BMJ 1970;
4(5728): 131–4.
Kracke RR and Parker FP. The relationship of drug therapy to
agranulocytosis. JAMA 1935; 105: 960–966.
Kracke RR. Agranulocytosis: Its classification; cases and comments illustrating the granulopenic trend from 8000 blood counts
in the South. Ann. Internal Med. 6: ... Am J Clin Pathol 1931; 1: 385.
Krakoff IH, Karnofsky DA and Burchenal JH. Effects of large doses of chloramphenicol on human
Med 1975; 253: 7-10.
Kuborn M. Poisoning by strammonium and by hyoscyamus. BMJ 1866; 1: 522–526.
Kühn B. The annual museum. BMJ 1894 August 25th; 2(1756): 414–423.
subjects. N Engl J
Kushimoto H and Aoki T. Toxic erythema with gene raised follicular pustules caused by streptomycin. Arch Dermatol 1981;
17: 444.
Lacassagne A. Apparition des adenocarcinomes mammaires chez des souris males traités par une substance œstrogène
synthetique. C R Séances Soc Biol. 1938; 129 : 641–3.
Lambin and Gerard. Rev Belge des Sci Med 1931; 3: 891.
Lancaster T, Swart AM and Jick H. Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British
general practice database. BMJ 1998; 316: 667.
Larrick GP. How the Food and Drug Administration evaluates New Drug Applications. Appendix A, In ‘Clinical Testing of New
Drugs’ Ed AD Herrick and M Cattell, Revere Publishing Company, Inc 1965.
Larsen K, Moller CE. A renal lesion caused by abuse of phenacetin. Acta Med Scand 1959; 164: 53–71.
Lasser KE, Seger DL, Yu DT, Karson AS, Fiskio JM, Seger AC, Shah NR, Gandhi TK, Rothschild JM and Bates DW.
Adherence to black box warnings for prescription medications in outpatients. Ann Intern Med 2006; 166(3): 338–344.
Latham R. The shorter Pepys. Folio Society 1985.
Laughlin S and Jackson R. A brief history of drug reactions. Clin Dermatol 1986;4(1): 1–14.
Launay C, Fabiani P, Grenet P, Hadenour A, Solignac and Strauss, Un nouveau cas d’acrodynia avec presence de mercure
dans les urines. Arch Fr Péd 28th Juin 1949;7: 21.
Le Clerc D. Histoire de la Médicine. Amsterdam, G Gallet, 1702; XVI: 188.
Le Quesne PM. Toxic substances and the nervous system: the role of clinical observation. J Neurol Neurosurger Psychiatry
1981; 44 :1–8.
Leader. Datura preparations banned in France. New Sci (22 August 1992).
Leader. Dipyrone hearing by the German drug authorities. Lancet September 27th 1986.
Leader. Streptomycin in tuberculosis. BMJ 1947; 2(4516): 136–138.
Leader. Today’s drugs. BMJ 1963;1:107-8.
Leake CD. The pharmacologic evaluation of new drugs. JAMA 1929; 93(21): 1632–36.
Lechat P. Periodical re-evaluation of the undesirable side effects of old drugs. An important mission of drug surveillance. Nouv
Presse Méd 1974; 3(24): 1571–3.